Company intelligence / Profile preview

Intega

Kirchheim bei München, Bavaria, Germany

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Intega specialized in design, development, and installation of high-purity media supply systems for pharma, biotech, and high-tech industries, focusing on water, chemical, and gas delivery and monitoring compliant with strict GMP/FDA requirements. In October 2023, it was acquired by Exyte to strengthen Exyte's offering in the Technology & Services business and will continue to operate within Exyte's portfolio.

Industry: Contract Manufacturing Organization

Partnerships

ExyteNimbusAir Liquide

Beyond the preview

Go deeper on Intega.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intega.

Explore the full profile